Mobility Opportunities Via Education/Experience (MOVE): Healthcare Impact Assessment

Study Overview
=================
Brief Summary
-----------------
The purpose of this study is to determine whether participation in the Mobility Opportunities Via Education (MOVE) program is associated with reduced use of healthcare for individuals with developmental disabilities.

Detailed Description
-----------------
The purpose of this study is to determine whether participation in the Mobility Opportunities Via Education (MOVE) program is associated with reduced use of healthcare for individuals with developmental disabilities. The investigators will compare healthcare events and healthcare expenditures for children and adults during intervals of at least one year when the subjects were participating in the MOVE program versus intervals of at least one year when the same individuals were not participating in the MOVE program based on health insurance records (i.e. Medicaid). Healthcare events are those which required professional medical services (associated with International Classification of Disease (ICD-XX) codes) or prescription medications. Healthcare events and healthcare expenditures will be reviewed from healthcare records obtained by Medicaid, Medicare, or private insurers and data will be compared between intervals.

Official Title
-----------------
Mobility Opportunities Via Education/Experience (MOVE): Healthcare Impact Assessment

Conditions
-----------------
Quality of Life, Health Care Utilization

Intervention / Treatment
-----------------
* Other: MOVE Program


Participation Criteria
=================
Eligibility Criteria
-----------------
CHILDREN: Inclusion Criteria Males and females 5-21 years old. Participated in the MOVE program pre-COVID and post-COVID. Did not participate for at least 4 months in the MOVE program during COVID. Has a healthcare payor(s) who makes healthcare records available upon request. Subjects whose legal guardians are willing to give informed consent to obtain and review healthcare records from the subject's primary (and secondary, if applicable) payors. CHILDREN: Exclusion Criteria Subjects who did not participate in the MOVE program through the duration of Interval #1 and Interval #3. Subjects whose legal guardians are unwilling to cooperate with the requests to obtain and review healthcare records and expenditures from the subject's primary (and secondary, if applicable) payors. ADULTS: Inclusion Criteria Males and females 22-65 years old. Participated in the MOVE program during Interval #1 and Interval #3. Did not participate for at least 4 months in the MOVE program during Interval #2. Has a healthcare payor(s) who makes healthcare records available upon request. Subjects who are willing to give informed consent and/or subjects' legal guardians who are willing to give informed assent to obtain and review healthcare records from the subject's primary (and secondary, if applicable) payors. ADULTS: Exclusion Criteria Subjects who did not participate in the MOVE program through the duration of Interval #1 and Interval #3. Subjects who are unwilling to give informed consent and/or subjects' legal guardians who are unwilling to give informed assent to cooperate with the requests to obtain and review healthcare records and expenditures from the subject's primary (and secondary, if applicable) payors.

Ages Eligible for Study
-----------------
Minimum Age: 5 Years
Maximum Age: 65 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Children in MOVE Program<br>Children 5-12 years old who participated in the MOVE program for at least 12 continuous months prior to March 1, 2020 and again for at least 12 continuous months after August 2021. | Other: MOVE Program<br>* Mobility Opportunities Via Education functional therapy program.<br>|
| Adults in MOVE Program<br>Adults 22-65 years old who participated in the MOVE program for at least 12 continuous months prior to March 1, 2020 and again for at least 12 continuous months after August 2021. | Other: MOVE Program<br>* Mobility Opportunities Via Education functional therapy program.<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Sum of Disability Adjusted Life Years | Healthcare events will be reviewed from the insurance record. International Classification of Disease (ICD) codes will be use to convert the healthcare event to disability adjusted life years. The sum of all disability adjusted life years will be calculated. | March 1, 2019 - April 30, 2023 | 
| Number of Healthcare Events | Healthcare events will be reviewed from the insurance record. The number of visits for professional healthcare will be determined. | March 1, 2019 - April 30, 2023 | 
| Cost of Healthcare Events | Healthcare events will be reviewed from the insurance record and total costs associated with healthcare utilization will be determined. | March 1, 2019 - April 30, 2023 | 
| Cost of Medication Use | Insurance records will be reviewed and the cost of medication used will be determined. | March 1, 2019 - April 30, 2023 | 
| Hip Range of Motion (Degrees) | From the Mobility Opportunities Via Education (MOVE) program records, hip range of motion (in degrees) will be determined. | March 1, 2019 - April 30, 2023 | 
| PedsQL Quality of Life Scale Score | From the Mobility Opportunities Via Education (MOVE) program records, the Pediatric Quality of Life Inventory (PedsQL) outcome instrument will be used to determine quality of life. The PedsQL is comprised of 7 questions with each question scored on a scale of 0-4. Higher scores indicate a higher quality of life. | March 1, 2019 - April 30, 2023 | 
| Top Down Motor Milestone Test Score | From the Mobility Opportunities Via Education (MOVE) program records, the Top Down Motor Milestone (TDMMT) score will be determined as an assessment of function | March 1, 2019 - April 30, 2023 |